Project Grant R21MH136644
Award Date
11/8/24
Completion Date
10/31/26
Dollars Obligated
$254K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $1,854,632 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Children's Hospital of Philadelphia (CHOP) to study the role of mitochondrial dysfunction and synaptic weakness in the pathogenesis of schizophrenia. The study aims to: Investigate mitochondrial biogenesis and mitophagy in induced pluripotent stem cell-derived neurons from individuals with 22q11.2 deletion syndrome, with and without schizophrenia, compared to...
The National Institute of Mental Health (NIMH) awarded a $2,272,048 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Research Foundation For The State University Of New York, doing business as Stony Brook University, to elucidate the role of the cholinergic system in the pathophysiology of schizophrenia. The 5-year study aims to replicate and extend prior observations relating in vivo cholinergic transmission, as measured by the vesicular acetylcholine transporter (VACHT) using...
The National Institute of Mental Health (NIMH) awarded a $246,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Mclean Hospital Corporation to observe brain lactate dynamics during a working memory task in patients with first episode and chronic schizophrenia. The study aims to use functional magnetic resonance spectroscopy (fMRS) to measure brain lactate, glutamate, and blood oxygen level dependent (BOLD) changes in response to a cognitive task. This research will help...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $908,174 to The Lieber Institute for Brain Development to conduct research aimed at understanding the cellular and molecular mechanisms underlying schizophrenia. The primary objectives of this 5-year research project are to: 1) Replicate and expand upon previous findings linking specific cellular phenotypes derived from patient-derived...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $3,093,740 to the Research Foundation for Mental Hygiene, Inc. (RFMH) at their Nathan S. Kline Institute Division to create an open data set of multimodal brain, physiological, and behavioral data for the study of schizophrenia. The project leverages the existing NIMH-funded Rockland Sample II (NKI-RSII) study, which collects extensive...
The National Institute of Mental Health (NIMH) awarded a $775,706 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Pittsburgh on August 9, 2024. The funding will support a prospective study examining the neural, molecular, and functional impacts of reducing anticholinergic burden (ACB) in 80 individuals aged 40-70 with schizophrenia spectrum disorders. The study aims to understand the effects of ACB reduction on cognition, quality of life, neural mechanisms...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), totaling $1,737,000.00, aims to identify the mitochondrial mechanisms driving learning and memory. The Max Planck Florida Institute for Neuroscience, a non-profit research organization, will conduct this 3-year research project from September 1, 2024 to August 31, 2027. The key objectives are to discover novel regulators that dictate the flexibility...
The National Institute of Mental Health (NIMH) awarded a $508,500 Project Grant (CFDA 93.242) to New York University School of Medicine to leverage electronic health records (EHRs) and advanced analytics to develop predictive models for key clinical outcomes in psychosis-related disorders. The 5-year project aims to: 1) Build machine learning models to forecast treatment response, illness severity, medical comorbidities, and diagnostic transitions in schizophrenia using longitudinal EHR data; 2)...
The National Institute of Mental Health (NIMH) awarded a $182,993 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the Research Foundation for Mental Hygiene, Inc. (RFMH), operating as the New York Psychiatric Center. The grant supports a 4-year research project from September 2024 to August 2028 that aims to investigate the role of acetylcholine release in the dorsomedial striatum and its relationship to thalamic activity during reversal learning. The project...
This $235,500 Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 (Mental Health Research Grants) will support a 2-year study to investigate decision-making processes in individuals with schizophrenia. The research aims to characterize attentional biases and neural activation patterns that underlie maladaptive decision-making, as well as evaluate the efficacy of cognitive strategies to improve reward-seeking behavior. Using neuroimaging, eye-tracking, and...